Gianni Gori Savellini

17PUBLICATIONS
22CO-AUTHORS
Molecular targetsMedical virologyNeurology and neuromuscular diseasesCancer therapy (excl. chemotherapy and radiation therapy)Virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 29, 2026
Redox-sensitive factors as targets of thiol compounds to hinder SARS-CoV-2 replication and inflammatory response.

|Mar 28, 2026
Molecular Epidemiology of Toscana Virus in Northern and Central Italy Using Metagenomic Next-Generation Sequencing.

Giulia Alessandri, Giada Beligni, Gianni Gori Savellini

|Feb 26, 2026
Metagenomic sequencing discloses the virome composition of mosquitoes and sandflies from Central-Southern Tuscany, Italy.

Gianni Gori Savellini, Giulia Alessandri, Giada Beligni

|May 25, 2024
Deletion of 82-85 N-Terminal Residues in SARS-CoV-2 Nsp1 Restricts Virus Replication.

Gianni Gori Savellini, Gabriele Anichini, Fabrizio Manetti

|Mar 30, 2023
Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID.

Maria Grazia Cusi, Anna Maria Di Giacomo, Gabriele Anichini

|Sep 23, 2022
Antibody Response against Circulating Omicron Variants 8 Months after the Third Dose of mRNA Vaccine.

Gabriele Anichini, Chiara Terrosi, Gianni Gori Savellini

Pageof 3

Frequent Collaborators

16 joint publications

Maria Grazia Cusi

12 joint publications

Gabriele Anichini

9 joint publications

Claudia Gandolfo

1 joint publications

Shibily Prathyumnan